/PRNewswire/ -- Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions, today announced positive interim results from...
Product StageFDA approved/pending approval
/PRNewswire/ -- Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions, announced today the appointment of Eden Ben...
Management ChangesProduct Stage
https://www.israelhayom.com/2022/06/13/israeli-shellfish-based-calcium-breakthrough-tested-in-space/
Outstanding Preliminary Results of A Clinical Trial Treating Moderate-To-Severe Covid-19 Patients, Conducted By Amorphical, An Israeli Biotechnology Company | News Direct
Customers
ืืืืจืคืืงื ืฉืืคืืงื ืกืืื ืืกืจืื ืื ืืืืืื ืืืฆืืช ืืืืืก ืฉื 30 ืืืืืื ืืืืจ ืืคื ืฉืืื ืฉื 160 ืืืืืื ืืืืจ
Investment
Amorphical signs China calcium capsule deal
PartnersExpand
Amorphical calcium absorption trial successful
Investment